ALLR — Allarity Therapeutics, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-12-21.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-01-28 | Ervin Jeffrey S CFO | Grant or award | 150.0K | 0.00 | 0 |
| 2026-01-28 | McLaughlin Gerald W. Director | Grant or award | 45.0K | 0.00 | 0 |
| 2026-01-28 | Graff Jeremy R. See Remarks | Grant or award | 133.3K | 0.00 | 0 |
| 2026-01-28 | Jensen Thomas CEO | Grant or award | 200.0K | 0.00 | 0 |
| 2026-01-07 | Hoeiland Jesper Director | Grant or award | 25.0K | 0.00 | 0 |
| 2026-01-07 | Graff Jeremy R. See Remarks | Grant or award | 133.3K | 0.00 | 0 |
| 2025-09-30 | Graff Jeremy R. See Remarks | Shares withheld for tax | 14.6K | 1.58 | 23.1K |
| 2025-09-30 | Graff Jeremy R. See Remarks | Option exercise | 39.5K | — | — |
| 2025-01-22 | Jensen Thomas CEO | Grant or award | 396.7K | 0.00 | 0 |
| 2025-01-22 | Epshinsky Alexander CFO | Grant or award | 29.5K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 248.6K | 228.1K |
| GEODE CAPITAL MANAGEMENT, LLC | 207.5K | 190.4K |
| VANGUARD CAPITAL MANAGEMENT LLC | 187.3K | 171.8K |
| STATE STREET CORP | 150.0K | 137.6K |
| VANGUARD FIDUCIARY TRUST CO | 81.7K | 74.9K |
| NORTHERN TRUST CORP | 52.4K | 48.1K |
| XTX Topco Ltd | 31.6K | 29.0K |
| TWO SIGMA INVESTMENTS, LP | 30.0K | 27.5K |
| UBS Group AG | 25.2K | 23.2K |
| TWO SIGMA SECURITIES, LLC | 13.4K | 12.3K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 8-K | 2026-08-14 | 2026-08-14 | on EDGAR ↗ |
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-07-01 | 2026-06-26 | on EDGAR ↗ |
| 8-K | 2026-06-22 | 2026-06-18 | on EDGAR ↗ |
| 8-K | 2026-06-02 | 2026-05-27 | on EDGAR ↗ |
| 10-Q | 2026-05-15 | 2026-03-31 | on EDGAR ↗ |
| 4 | 2026-05-14 | 2026-01-28 | on EDGAR ↗ |
| 4 | 2026-05-11 | 2026-01-28 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Allarity Therapeutics, Inc. (ALLR) filed form 8-K · 2026-08-14 · SEC EDGAR
- Allarity Therapeutics reports Q2 results · 2026-08-14
- Allarity Therapeutics, Inc. (ALLR) filed form 8-K · 2026-08-14 · SEC EDGAR
- Allarity Therapeutics, Inc. (ALLR) filed form 10-Q · 2026-08-14 · SEC EDGAR
Ask the AI about ALLR
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →